Bone Marrow TransplantationTransplantation, HomologousBone MarrowHematopoietic Stem Cell TransplantationBone Marrow CellsTransplantation, AutologousGraft vs Host DiseaseStem CellsStem Cell TransplantationTransplantation ConditioningWhole-Body IrradiationTissue DonorsHematopoietic Stem CellsGraft SurvivalKidney TransplantationAnemia, AplasticLeukemiaBone and BonesHistocompatibility TestingHematologic NeoplasmsTransplantation ChimeraHistocompatibilityBusulfanImmunosuppressive AgentsTransplantationTreatment OutcomeGraft RejectionBone Marrow PurgingLiver TransplantationRecurrenceCytomegalovirus InfectionsTime FactorsCyclophosphamideCombined Modality TherapyRetrospective StudiesHeart TransplantationTransplantation, IsogeneicHematopoiesisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunocompromised HostHepatic Veno-Occlusive DiseasePeripheral Blood Stem Cell TransplantationLeukemia, Myeloid, AcuteImmunosuppressionMice, Inbred C57BLBone Marrow DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaLung TransplantationTransplantsOpportunistic InfectionsCell DifferentiationTransplantation ImmunologyRemission InductionCyclosporineAcute DiseaseSurvival AnalysisHematologic DiseasesRadiation ChimeraLymphocyte DepletionLeukocyte TransfusionHLA AntigensLymphoma, Non-HodgkinEmbryonic Stem CellsLeukemia, MyeloidSurvival RateBone Marrow ExaminationFollow-Up StudiesT-LymphocytesHematopoietic Stem Cell MobilizationMultiple MyelomaAdult Stem CellsMyelodysplastic SyndromesAntineoplastic Combined Chemotherapy ProtocolsMesenchymal Stem Cell TransplantationFatal OutcomeColony-Forming Units AssayBone RemodelingGraft vs Host ReactionCord Blood Stem Cell TransplantationAntigens, CD34AspergillosisBone Marrow NeoplasmsCells, CulturedMycosesFlow CytometryChimeraGraft vs Leukemia EffectCytomegalovirusOrgan TransplantationMelphalanGranulocyte Colony-Stimulating FactorPostoperative ComplicationsSevere Combined ImmunodeficiencyDisease-Free SurvivalLymphocyte TransfusionLiving DonorsCell TransplantationPrognosisChimerismPluripotent Stem Cells